It has been suggested that limited expression of TIMP-1 in the blood serum of patients after chemotherapy is a good prognostic factor for patients with ovarian cancer, although it is not entirely clear whether the inhibition of TIMP-1 expression in the neoplastic tissue of such patients may indicate the same prognosis [75]. This evidence concerns the gene TIMP1 and ovarian carcinoma.